Back to Search Start Over

Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease

Authors :
Berti, A
Della-Torre, E
Gallivanone, F
Canevari, C
Milani, R
Lanzillotta, M
Campochiaro, C
Ramirez, G
Bozzalla Cassione, E
Bozzolo, E
Pedica, F
Castiglioni, I
Arcidiacono, P
Balzano, G
Falconi, M
Gianolli, L
Dagna, L
Berti A
Della-Torre E
Gallivanone F
Canevari C
Milani R
Lanzillotta M
Campochiaro C
Ramirez GA
Bozzalla Cassione E
Bozzolo E
Pedica F
CASTIGLIONI I
Arcidiacono PG
Balzano G
Falconi M
Gianolli L
Dagna L
Berti, A
Della-Torre, E
Gallivanone, F
Canevari, C
Milani, R
Lanzillotta, M
Campochiaro, C
Ramirez, G
Bozzalla Cassione, E
Bozzolo, E
Pedica, F
Castiglioni, I
Arcidiacono, P
Balzano, G
Falconi, M
Gianolli, L
Dagna, L
Berti A
Della-Torre E
Gallivanone F
Canevari C
Milani R
Lanzillotta M
Campochiaro C
Ramirez GA
Bozzalla Cassione E
Bozzolo E
Pedica F
CASTIGLIONI I
Arcidiacono PG
Balzano G
Falconi M
Gianolli L
Dagna L
Publication Year :
2017

Abstract

Objective. [18F]Fluorodeoxyglucose (18F-FDG) PET/CT is increasingly used to assess organ involvement and response to treatment in IgG4-related disease (IgG4-RD), but clear correlations between 18F-FDG uptake and disease activity have not been established yet. We aimed to correlate the intensity and distribution of 18F-FDG uptake with validated clinical, serological and immunological parameters of IgG4-RD activity. Methods. Twenty patients with active IgG4-RD underwent a baseline 18F-FDG PET/CT. Ten patients repeated 18F-FDG PET/CT after immunosuppressive treatments. 18F-FDG tissue uptake was measured using the standardized uptake value corrected for the partial volume effect (PVC-SUV) and the total lesion glycolysis (TLG) with (TLGtot+ln) and without (TLGtot-ln) lymph nodes. Disease activity was assessed by means of clinical parameters [IgG4-RD Responder Index (RI)], serological (ESR and CRP) and immunological (serum IgG4 and circulating plasmablasts) biomarkers. The enhanced liver fibrosis score was exploited as a biomarker for fibroblast activation. Results. Thirteen (65%) patients had two or more organs affected by IgG4-RD. All patients had active IgG4-RD as defined by a median IgG4-RD RI value of 9 (range 6-15; normal < 3). Serum IgG4 and plasmablasts were elevated in 85% of patients. Circulating plasmablasts positively correlated with PVCSUV (P = 0.027), inversely correlated with TLGtot-ln (P = 0.023) and did not correlate with TLGtot+ln (P > 0.05). No statistically significant correlation was found between PVC-SUV or TLG and IgG4-RD RI, ESR, CRP, serum IgG4 or enhanced liver fibrosis score (P > 0.05). Clinical response to immunosuppressive therapies was associated with a consensual reduction of circulating plasmablasts, PVC-SUV, TLGtot+ln and TLGtot-ln values (P < 0.05 for all comparisons). Conclusions. 18F-FDG uptake of IgG4-RD lesions reflects immunological perturbations of the B cell compartment rather than fibroblast activation and extracellula

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1308931669
Document Type :
Electronic Resource